chartexchange

Pelthos Therapeutics Inc (PTHS) (Q3 2026) Earnings Call Highlights: ZELSUVMI Revenue Jumps 114% ...

GuruFocus | Nov 12, 2026 6:05 PM EST

Pelthos Therapeutics Inc (PTHS) posted $15.2 million in ZELSUVMI net revenue, narrowed its net loss to $7.9 million, and outlined plans for two new product launches and a late-stage rare disease… Related Stocks: PTHS ,

Read original article